|
良性前列腺增生微创技术的研究进展
|
Abstract:
良性前列腺增生作为泌尿系疾病中常见的老年疾病,主要表现为进行性排尿困难。其经典的手术方式为经尿道前列腺电切术,该手术方式仍存在术后出血、影响射精功能等术后并发症,经过多年的发展,对该术式的改进,出现前列腺剜除术,并把激光应用于手术。与此同时,前列腺的微创治疗也蓬勃发展,前列腺动脉栓塞术、前列腺水蒸气消融、临时植入式镍钛装置等微创治疗逐渐应用于临床治疗。本文就良性前列腺增生的各种手术治疗和微创治疗的研究进展作一综述。
Benign prostatic hyperplasia, as a common elderly disease among urological diseases, mainly manifests as progressive urination difficulty. The classic surgical method is transurethral resection of the prostate. This surgical method still has postoperative complications such as postoperative bleeding and impact on ejaculation function. After years of development, this surgical method has been improved, and prostatic enucleation has emerged, and use lasers in surgery. At the same time, minimally invasive treatments for the prostate are also booming, and minimally invasive treatments such as prostatic artery embolization, prostate water vapor ablation, and temporary implantable nickel-titanium devices are gradually being used in clinical treatment. This article reviews the research progress of various surgical treatments and minimally invasive treatments for benign prostatic hyperplasia.
[1] | Xu, X.F., Liu, G.X., Guo, Y.S., et al. (2021) Global, Regional, and National Incidence and Year Lived with Disability for Benign Prostatic Hyperplasia from 1990 to 2019. American Journal of Men’s Health, 15. https://doi.org/10.1177/15579883211036786 |
[2] | Carson, C.R. and Rittmaster, R. (2003) The Role of Dihydrotestosterone in Benign Prostatic Hyperplasia. Urology, 61, 2-7. https://doi.org/10.1016/S0090-4295(03)00045-1 |
[3] | Chapple, C.R. (2005) A Comparison of Varying α-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. Reviews in Urology, 7, S22-S30. |
[4] | Dahm, P., Brasure, M., Macdonald, R., et al. (2017) Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. European Urology, 71, 570-581. https://doi.org/10.1016/j.eururo.2016.09.032 |
[5] | Malde, S., Umbach, R., Wheeler, J.R., et al. (2021) A Systematic Review of Patients’ Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms. European Urology, 79, 796-809. https://doi.org/10.1016/j.eururo.2020.12.019 |
[6] | Leslie, S.W., Chargui, S. and Stormont, G. (2023) Transurethral Resection of the Prostate. |
[7] | Wang, B., Zhang, S., Sun, C., et al. (2020) Comparison between a Transurethral Prostate Split and Transurethral Prostate Resection for Benign Prostatic Hyperplasia Treatment in a Small Prostate Volume: A Prospective Controlled Study. Annals of Translational Medicine, 8, Article 1016. https://doi.org/10.21037/atm-20-5462 |
[8] | Rassweiler, J., Teber, D., Kuntz, R., et al. (2006) Complications of Transurethral Resection of the Prostate (TURP)—Incidence, Management, and Prevention. European Urology, 50, 969-980. https://doi.org/10.1016/j.eururo.2005.12.042 |
[9] | Alexander, C.E., Scullion, M., Omar, M.I., et al. (2020) Reprint—Bipolar vs. Monopolar Transurethral Resection of the Prostate for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Obstruction: A Cochrane Review. Canadian Urological Association Journal, 14, 423-430. https://doi.org/10.5489/cuaj.6464 |
[10] | Gupta, A., Priyadarshi, S., Vyas, N. and Sharma, G. (2021) Efficacy of Tranexamic Acid in Decreasing Primary Hemorrhage in Transurethral Resection of the Prostate: A Novel Combination of Intravenous and Topical Approach. Urology Annals, 13, 238-242. https://doi.org/10.5489/cuaj.6464 |
[11] | Tsai, M.Y., Chen, C.H., Chiang, P.H. and Chiang, P.C. (2023) Combination of 180-W GreenLight XPS Laser and Bipolar Transurethral Resection of Prostate for the Treatment of Large Prostates beyond 100 Ml: A Novel Hybrid Technique. International Urology and Nephrology, 55, 2741-2746. https://doi.org/10.1007/s11255-023-03723-w |
[12] | Yang, C.Y., Chen, G.M., Wu, Y.X., et al. (2023) Clinical Efficacy and Complications of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate. European Journal of Medical Research, 28, Article No. 83. https://doi.org/10.1186/s40001-023-00989-9 |
[13] | Bolliger, M., Kroehnert, J.A., Molineus, F., et al. (2018) Experiences with the Standardized Classification of Surgical Complications (Clavien-Dindo) in General Surgery Patients. European Surgery, 50, 256-261. https://doi.org/10.1007/s10353-018-0551-z |
[14] | Zou, Z., Zhang, L., Cai, K., et al. (2023) Feasibility and Safety of Bipolar-Plasmakinetic Transurethral Enucleation and Resection of the Prostate in Day Surgery Mode. Journal of Zhejiang University, 52, 148-155. https://doi.org/10.3724/zdxbyxb-2022-0643 |
[15] | Kuntz, R.M., Ahyai, S., Lehrich, K., et al. (2004) Transurethral Holmium Laser Enucleation of the Prostate versus Transurethral Electrocautery Resection of the Prostate: A Randomized Prospective Trial in 200 Patients. Journal of Urology, 172, 1012-1016. https://doi.org/10.1097/01.ju.0000136218.11998.9e |
[16] | He, W., Ding, T., Niu, Z., et al. (2023) Reoperation after Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review. Frontiers in Endocrinology, 14, Article 1287212. https://doi.org/10.3389/fendo.2023.1287212 |
[17] | Tamalunas, A., Westhofen, T., Schott, M., et al. (2022) Holmium Laser Enucleation of the Prostate: A Truly Size-Independent Method? LUTS: Lower Urinary Tract Symptoms, 14, 17-26. https://doi.org/10.1111/luts.12404 |
[18] | Porto, J.G., Blachman-Braun, R., Delgado, C., et al. (2023) Is Holmium Laser Enucleation of the Prostate Truly Size-Independent? A Critical Evaluation at the Extreme Ends of the Spectrum. Urology, 182, 204-210. https://doi.org/10.1016/j.urology.2023.09.002 |
[19] | Nishino, T., Endo, F., Nakama, D., et al. (2024) Holmium Laser Enucleation of the Prostate as a Secondary Surgery Following Prostatic Urethral Lift. IJU Case Reports, 7, 34-37. https://doi.org/10.1002/iju5.12661 |
[20] | Shoma, A.M., Ghobrial, F.K., El-Tabey, N., et al. (2023) A Randomized Trial of Holmium Laser vs Thulium Laser vs Bipolar Enucleation of Large Prostate Glands. BJU International, 132, 686-695. https://doi.org/10.1111/bju.16174 |
[21] | Wen, Z., Deng, X.Z., Wang, L., et al. (2023) Efficacy and Safety of Transurethral Thulium Laser Enucleation versus Robot-Assisted Prostatectomy for Large-Volume Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. Journal of Robotic Surgery, 17, 2633-2646. https://doi.org/10.1007/s11701-023-01715-7 |
[22] | Gao, Y.A., Huang, Y., Zhang, R., et al. (2014) Benign Prostatic Hyperplasia: Prostatic Arterial Embolization versus Transurethral Resection of the Prostate—A Prospective, Randomized, and Controlled Clinical Trial. Radiology, 270, 920-928. https://doi.org/10.1148/radiol.13122803 |
[23] | De Assis, A.M., Moreira, A.M., Carnevale, F.C., et al. (2021) Role of Ultrasound Elastography in Patient Selection for Prostatic Artery Embolization. Journal of Vascular and Interventional Radiology, 32, 1410-1416. https://doi.org/10.1016/j.jvir.2021.07.018 |
[24] | Radwan, A., Farouk, A., Higazy, A., et al. (2020) Prostatic Artery Embolization versus Transurethral Resection of the Prostate in Management of Benign Prostatic Hyperplasia. Prostate International, 8, 130-133. https://doi.org/10.1016/j.prnil.2020.04.001 |
[25] | Bilhim, T., Costa, N.V., Torres, D., et al. (2022) Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients over a 10-Year Period. CardioVascular and Interventional Radiology, 45, 1324-1336. https://doi.org/10.1007/s00270-022-03199-8 |
[26] | Guerra, X., Sapoval, M., Querub, C., et al. (2023) Repeat Prostatic Artery Embolization with the Addition of a Liquid Embolic Agent: Short-Term Results. Academic Radiology. https://doi.org/10.1016/j.acra.2023.10.005 |
[27] | Ayyagari, R., Powell, T., Staib, L., et al. (2020) Prostatic Artery Embolization Using 100-300-Mum Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-Up. Journal of Vascular and Interventional Radiology, 31, 99-107. https://doi.org/10.1016/j.jvir.2019.08.005 |
[28] | Zhiyu, Z., Zhen, S., Qi, Z., et al. (2023) Two-Year Outcomes after Transurethral Prostate Resection Post-Prostatic Artery Embolization versus Transurethral Prostate Resection Alone for Giant Benign Prostatic Hyperplasia. Urology Journal, 20, 361-368. |
[29] | Wu, X., Zhou, A., Heller, M. and Kohlbrenner, R. (2022) Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis. Journal of Vascular and Interventional Radiology, 33, 1605-1615. https://doi.org/10.1016/j.jvir.2022.08.006 |
[30] | Xu, X.J., Li, J., Huang, X.Z. and Liu, Q. (2020) An Updated Meta-Analysis of Prostatic Arterial Embolization versus Transurethral Resection of the Prostate in the Treatment of Benign Prostatic Hyperplasia. World Journal of Urology, 38, 2455-2468. https://doi.org/10.1007/s00345-019-03044-7 |
[31] | Arezki, A., Sadri, I., Couture, F., et al. (2021) Reasons to Go for Rezum Steam Therapy: An Effective and Durable Outpatient Minimally Invasive Procedure. World Journal of Urology, 39, 2307-2313. https://doi.org/10.1007/s00345-020-03457-9 |
[32] | Alegorides, C., Fourmarier, M., Eghazarian, C., et al. (2020) Treatment of Benign Prostate Hyperplasia Using the Rezum? Water Vapor Therapy System: Results at One Year. Progrès en Urologie, 30, 624-631. https://doi.org/10.1016/j.purol.2020.05.004 |
[33] | Campobasso, D., Siena, G., Chiodini, P., et al. (2023) Composite Urinary and Sexual Outcomes after Rezum: An Analysis of Predictive Factors from an Italian Multi-Centric Study. Prostate Cancer and Prostatic Diseases, 26, 410-414. https://doi.org/10.1038/s41391-022-00587-6 |
[34] | Bausch, K., Zahiti, L., Schrutt, M., et al. (2023) Water Vapor Thermal Therapy of Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Efficacy and Safety Analysis of a Real-World Cohort of 211 Patients. World Journal of Urology, 41, 1605-1612. https://doi.org/10.1007/s00345-023-04395-y |
[35] | (2022) The Global, Regional, and National Burden of Benign Prostatic Hyperplasia in 204 Countries and Territories from 2000 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet Healthy Longevity, 3, E754-E776. |
[36] | Balakrishnan, D., Jones, P. and Somani, B.K. (2020) ITIND: The Second-Generation Temporary Implantable Nitinol Device for Minimally Invasive Treatment of Benign Prostatic Hyperplasia. Therapeutic Advances in Urology, 12. https://doi.org/10.1177/1756287220934355 |
[37] | Elterman, D., Gao, B., Zorn, K.C., et al. (2021) How I Do It: Temporarily Implanted Nitinol Device (ITind). The Canadian Journal of Urology, 28, 10788-10793. |
[38] | Porpiglia, F., Fiori, C., Bertolo, R., et al. (2015) Temporary Implantable Nitinol Device (TIND): A Novel, Minimally Invasive Treatment for Relief of Lower Urinary Tract Symptoms (LUTS) Related to Benign Prostatic Hyperplasia (BPH): Feasibility, Safety and Functional Results at 1 Year of Follow-Up. BJU International, 116, 278-287. https://doi.org/10.1111/bju.12982 |
[39] | Porpiglia, F., Fiori, C., Bertolo, R., et al. (2018) 3-Year Follow-Up of Temporary Implantable Nitinol Device Implantation for the Treatment of Benign Prostatic Obstruction. BJU International, 122, 106-112. https://doi.org/10.1111/bju.14141 |
[40] | Amparore, D., De Cillis, S., Schulman, C., et al. (2023) Temporary Implantable Nitinol Device for Benign Prostatic Hyperplasia-Related Lower Urinary Tract Symptoms: Over 48-Month Results. Minerva Urology and Nephrology, 75, 743-751. https://doi.org/10.23736/S2724-6051.23.05322-3 |
[41] | Chin, P.T., Bolton, D.M., Jack, G., et al. (2012) Prostatic Urethral Lift: Two-Year Results after Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urology, 79, 5-11. https://doi.org/10.1016/j.urology.2011.10.021 |
[42] | Magistro, G., Stief, C.G. and Gratzke, C. (2017) Prostatic Urethral Lift versus Transurethral Resection of the Prostate (TURP). Current Urology Reports, 18, Article No. 82. https://doi.org/10.1007/s11934-017-0725-4 |
[43] | Feiertag, J.H., Kane, J.A. and Clark, J.Y. (2024) Incidence of Surgical Reintervention for Benign Prostatic Hyperplasia Following Prostatic Urethral Lift, Transurethral Resection of the Prostate, and Photoselective Vaporization of the Prostate: A TriNetX Analysis. European Urology Open Science, 59, 63-70. https://doi.org/10.1016/j.euros.2023.11.009 |
[44] | Rochester, M., Doherty, R., Page, T., et al. (2024) Prostatic Urethral Lift for Subjects in Urinary Retention (PULSAR): 12-Month Results of A Prospective Controlled Trial Compared with Real-World Outcomes. BJUI Compass, 5, 60-69. https://doi.org/10.1002/bco2.280 |
[45] | Elterman, D., Shepherd, S., Saadat, S.H., et al. (2021) Prostatic Urethral Lift (UroLift) versus Convective Water Vapor Ablation (Rezum) for Minimally Invasive Treatment of BPH: A Comparison of Improvements and Durability in 3-Year Clinical Outcomes. The Canadian Journal of Urology, 28, 10824-10833. |